Blackmores first consideration in clinical research is the safety and welfare of any research participants. Blackmores involvement with clinical research is to further the health and wellbeing of its consumers by supporting studies that will have the potential to result in clinically effective products of appropriate cost and risk benefit. Blackmores will help support and foster the complementary medicine research community both in Australia and Asia to help ensure the long-term underpinning of research and development. Blackmores will support generic, non-commercial clinical research that has the potential to contribute to the wellbeing of the public.
Researchers must ensure that the most appropriate and robust methodology is used to ensure a high standard of internal validity. Blackmores sponsored clinical research will be adequately funded to provide the best opportunity to reach a clinically meaningful outcome in a timely fashion.
Blackmores sponsored research will be conducted to standards appropriate to the scope and nature of the research in question – at all times, the safety and welfare of any participants will be paramount.
Blackmores upholds the ethical and legal rights of the researcher to publish the outcomes of any clinical research regardless of the outcomes of the research. Blackmores will communicate the results of any research in an appropriate manner consistent with the principles of the research organisation and its researchers, as well as any legal and ethical principles held internally by Blackmores.
Commercialisation (sale and promotion) of research outcomes will be consistent with the factual evidence presented by the researchers.